ICGI Articles

• Clinical utility of chromatin analysis

  Published: 20.08.2018

  Kleppe A, Danielsen HE

  Oncotarget. 2018 Aug 21;9(65):32406-32407. doi: 10.18632/oncotarget.25991. eCollection 2018 Aug 21.

  PubMed 30197751

  For more information, please contact: Andreas Kleppe

• Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

  Published: 01.07.2018

  Domingo E, Camps C, Kaisaki PJ, Parsons MJ, Mouradov D, Pentony MM, Makino S, Palmieri M, Ward RL, Hawkins NJ, Gibbs P, Askautrud H, Oukrif D, Wang H, Wood J, Tomlinson E, Bark Y, Kaur K, Johnstone EC, Palles C, Church DN, Novelli M, Danielsen HE, Sherlock J, Kerr D et al.

  Lancet Gastroenterol Hepatol

  PubMed 30042065

  For more information, please contact: Hanne Askautrud

• Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers

  Published: 17.04.2018

  Nielsen B, Kleppe A, Hveem TS, Pradhan M, Syvertsen RA, Nesheim JA, Kristensen GB, Trovik J, Kerr DJ, Albregtsen F, Danielsen HE

  J Natl Cancer Inst. 2018 Apr 18. doi: 10.1093/jnci/djy063

  PubMed 29684152

  For more information, please contact: Birgitte Nielsen

• Chromatin organisation and cancer prognosis: a pan-cancer study

  Published: 31.01.2018

  Kleppe A, Albregtsen F, Vlatkovic L, Pradhan M, Nielsen B, Hveem TS, Askautrud HA, Kristensen GB, Nesbakken A, Trovik J, Wæhre H, Tomlinson I, Shepherd NA, Novelli M, Kerr DJ, Danielsen HE

  Lancet Oncol DOI: https://doi.org/10.1016/S1470-2045(17)30899-9

  PubMed 29402700

  For more information, please contact: Andreas Kleppe

• Prognostic markers for colorectal cancer; estimating ploidy and stroma

  Published: 26.12.2017

  Danielsen HE, Hveem TS, Domingo E, Pradhan M, Kleppe A, Syvertsen RA, Kostolomov I, Nesheim JA, Askautrud HA, Nesbakken A, Lothe RA, Svindland A, Shepherd N, Novelli M, Johnstone E, Tomlinson I, Kerr R, Kerr DJ

  Ann Oncol

  PubMed 29293881

  For more information, please contact: Håvard E. Greger Danielsen

• Role of PLZF as a tumor suppressor in prostate cancer

  Published: 07.08.2017

  Jin Y, Nenseth HZ, Saatcioglu F (2017)

  Oncotarget, 8 (41), 71317-71324

  PubMed 29050363

  For more information, please contact: Fahri Saatcioglu

• Tumour heterogeneity poses a significant challenge to cancer biomarker research

  Published: 15.06.2017

  Cyll K, Ersvær E, Vlatkovic L, Pradhan M, Kildal W, Avranden Kjær M, Kleppe A, Hveem TS, Carlsen B, Gill S, Löffeler S, Haug ES, Wæhre H, Sooriakumaran P, Danielsen HE

  Br J Cancer

  PubMed 28618431

  For more information, please contact: Karolina Cyll

• Computer-aided diagnostics in digital pathology

  Published: 14.06.2017

  Bengtsson E, Danielsen H, Treanor D, Gurcan MN, MacAulay C, Molnár B

  Cytometry A. 2017 Jun;91(6):551-554. doi: 10.1002/cyto.a.23151.

  Pubmed 28640523

  For more information, please contact: Håvard E. Greger Danielsen

• BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer

  Published: 01.03.2017

  López-García C, Sansregret L, Domingo E, McGranahan N, Hobor S, Birkbak NJ, Horswell S, Grönroos E, Favero F, Rowan AJ, Matthews N, Begum S, Phillimore B, Burrell R, Oukrif D, Spencer-Dene B, Kovac M, Stamp G, Stewart A, Danielsen H, Novelli M, Tomlinson I, Swanton C

  Cancer Cell, 31 (1), 79-93

  PubMed 28073006

  For more information, please contact: Håvard E. Greger Danielsen

• Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG

  Published: 08.12.2016

  Silva MP, Barros-Silva JD, Ersvær E, Kildal W, Hveem TS, Pradhan M, Vieira J, Teixeira MR, Danielsen HE

  Transl Oncol, 9 (6), 575-582

  PubMed 27916292

  For more information, please contact: Elin Ersvær

« 1 2 Previous Next »